 | Ovid Therapeutics Inc. | |||
| NMS : OVID || Location: United States | ||||
$2.99-0.16 (-5.08%) |
0.11 M | 2.99 - 3.14 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 2.798 M |
| March 28, 2024 | 2.801 M |
| March 15, 2024 | 3.668 M |
| Feb. 29, 2024 | 3.654 M |
| Feb. 15, 2024 | 3.595 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.05 | -0.22 | -333.93% |
| 09/30/2023 | -0.19 | -0.16 | 16.84% |
| 06/30/2023 | -0.21 | -0.18 | 13.75% |
| 03/31/2023 | -0.17 | -0.19 | -8.76% |
| 12/31/2022 | -0.19 | -0.16 | 13.93% |
OVID Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 70.710M | Shares Float | 45.095M |
| Short Float | 2.798M | Market Cap | 211.42M |
| Institution ownership | 64.71% | Insider ownership | 15.990% |
| Earnings Date | 05/03/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.74 | Forward EPS | -0.28 |